135 related articles for article (PubMed ID: 18087188)
1. What is the best time to evaluate treatment response after radiofrequency ablation of hepatocellular carcinoma using contrast-enhanced sonography?
Zhou P; Kudo M; Minami Y; Chung H; Inoue T; Fukunaga T; Maekawa K
Oncology; 2007; 72 Suppl 1():92-7. PubMed ID: 18087188
[TBL] [Abstract][Full Text] [Related]
2. Treatment response assessment of radiofrequency ablation for hepatocellular carcinoma: usefulness of virtual CT sonography with magnetic navigation.
Minami Y; Kitai S; Kudo M
Eur J Radiol; 2012 Mar; 81(3):e277-80. PubMed ID: 21392916
[TBL] [Abstract][Full Text] [Related]
3. Planning Sonography Using Real-time Virtual Sonography and Contrast-enhanced Sonography for Radiofrequency Ablation of Inconspicuous Hepatocellular Carcinoma Nodules.
Toshikuni N; Takuma Y; Tomokuni J; Yamamoto H
Hepatogastroenterology; 2015 May; 62(139):661-6. PubMed ID: 26897949
[TBL] [Abstract][Full Text] [Related]
4. Evaluation using contrast-enhanced harmonic gray scale sonography after radio frequency ablation of small hepatocellular carcinoma: sonographic-histopathologic correlation.
Morimoto M; Nozawa A; Numata K; Shirato K; Sugimori K; Kokawa A; Tomita N; Saitou T; Nakatani Y; Imada T; Tanaka K
J Ultrasound Med; 2005 Mar; 24(3):273-83. PubMed ID: 15723840
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the ablated area after radiofrequency ablation by contrast-enhanced sonography; comparison with virtual sonography with magnetic navigation.
Koda M; Mandai M; Matono T; Sugihara T; Nagahara T; Ueki M; Ohyama K; Hosho K; Murawaki Y
Clin Imaging; 2010; 34(1):60-4. PubMed ID: 20122522
[TBL] [Abstract][Full Text] [Related]
6. Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography.
Rhim H; Choi D; Kim YS; Lim HK; Choe BK
Eur J Radiol; 2010 Aug; 75(2):253-8. PubMed ID: 19427152
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation assisted by real-time virtual sonography and CT for hepatocellular carcinoma undetectable by conventional sonography.
Nakai M; Sato M; Sahara S; Takasaka I; Kawai N; Minamiguchi H; Tanihata H; Kimura M; Takeuchi N
Cardiovasc Intervent Radiol; 2009 Jan; 32(1):62-9. PubMed ID: 18987911
[TBL] [Abstract][Full Text] [Related]
8. Prediction of the ablated area by the spread of microbubbles during radiofrequency ablation of hepatocellular carcinoma.
Nouso K; Shiraga K; Uematsu S; Okamoto R; Harada R; Takayama S; Kawai W; Kimura S; Ueki T; Okano N; Nakagawa M; Mizuno M; Araki Y; Shiratori Y
Liver Int; 2005 Oct; 25(5):967-72. PubMed ID: 16162154
[TBL] [Abstract][Full Text] [Related]
9. Modified technique for determining therapeutic response to radiofrequency ablation therapy for hepatocellular carcinoma using US-volume system.
Hiraoka A; Hirooka M; Koizumi Y; Hidaka S; Uehara T; Ichikawa S; Hasebe A; Miyamoto Y; Ninomiya T; Michitaka K; Horiike N; Yamashita Y; Hiasa Y; Matsuura B; Onji M
Oncol Rep; 2010 Feb; 23(2):493-7. PubMed ID: 20043112
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the ablated area after radiofrequency ablation by the spread of bubbles: comparison with virtual sonography with magnetic navigation.
Koda M; Mandai M; Matono T; Sugihara T; Nagahara T; Ueki M; Ohyama K; Hosho K; Murawaki Y
Hepatogastroenterology; 2011; 58(110-111):1638-42. PubMed ID: 22086693
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation assisted by real-time virtual sonography for hepatocellular carcinoma inconspicuous under sonography and high-risk locations.
Lee CH; Chen WT; Lin CC; Teng W; Lin SM; Chiu CT
Kaohsiung J Med Sci; 2015 Aug; 31(8):413-9. PubMed ID: 26228280
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography.
Wen YL; Kudo M; Zheng RQ; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
AJR Am J Roentgenol; 2003 Jul; 181(1):57-63. PubMed ID: 12818830
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation.
Kisaka Y; Hirooka M; Kumagi T; Uehara T; Hiasa Y; Kumano S; Tanaka H; Michitaka K; Horiike N; Mochizuki T; Onji M
Liver Int; 2006 Dec; 26(10):1241-7. PubMed ID: 17105590
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
Meloni MF; Goldberg SN; Livraghi T; Calliada F; Ricci P; Rossi M; Pallavicini D; Campani R
AJR Am J Roentgenol; 2001 Aug; 177(2):375-80. PubMed ID: 11461867
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT.
Inoue T; Kudo M; Hatanaka K; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Sakurai T; Ueshima K; Nishida N
Oncology; 2013; 84 Suppl 1():51-7. PubMed ID: 23428859
[TBL] [Abstract][Full Text] [Related]
16. Postablation assessment using follow-up registration of CT images before and after radiofrequency ablation (RFA): prospective evaluation of midterm therapeutic results of RFA for hepatocellular carcinoma.
Shin S; Lee JM; Kim KW; Joo I; Han JK; Choi BI; Klotz E
AJR Am J Roentgenol; 2014 Jul; 203(1):70-7. PubMed ID: 24951197
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of indocyanine green removal from blood can be used to predict the size of the area removed by radiofrequency ablation of hepatic nodules.
Sato S; Miyake T; Mishiro T; Furuta K; Azumi T; Oshima N; Takahashi Y; Rumi MA; Ishihara S; Adachi K; Amano Y; Kinoshita Y
J Gastroenterol Hepatol; 2006 Nov; 21(11):1714-9. PubMed ID: 16984595
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced sonography-guided radiofrequency ablation for the local recurrence of previously treated hepatocellular carcinoma undetected by B-mode sonography.
Miyamoto N; Hiramatsu K; Tsuchiya K; Sato Y
J Clin Ultrasound; 2010 Sep; 38(7):339-45. PubMed ID: 20572066
[TBL] [Abstract][Full Text] [Related]
19. Four-dimensional ultrasonography for therapeutic radiofrequency ablation for hepatocellular carcinoma.
Hotta N; Maeno T; Ayada M; Sato K; Ishikawa T; Okumura A; Matsumoto E; Fukuzawa Y; Kakumu S
Hepatogastroenterology; 2006; 53(70):521-5. PubMed ID: 16995453
[TBL] [Abstract][Full Text] [Related]
20. Kupffer Imaging by Contrast-Enhanced Sonography With Perfluorobutane Microbubbles Is Associated With Outcomes After Radiofrequency Ablation of Hepatocellular Carcinoma.
Nuta J; Tamai H; Mori Y; Shingaki N; Maeshima S; Shimizu R; Maeda Y; Moribata K; Niwa T; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
J Ultrasound Med; 2016 Feb; 35(2):359-71. PubMed ID: 26782163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
